射血分数保留的心力衰竭合并房颤的发病机制及治疗进展  

The Pathogenesis and Treatment Progress of Heart Failure with Preserved Ejection Frac-tion and Atrial Fibrillation

作　　者：刘青华 刘新宏[2] 杨禹娟[2] 赵小利 

机构地区：[1]西安医学院,陕西 西安 [2]陕西省人民医院心血管内科,陕西 西安

出　　处：《临床医学进展》2022年第8期7552-7558,共7页Advances in Clinical Medicine

摘　　要：射血分数保留的心力衰竭(HFpEF)合并房颤(AF)发病率越来越高,是导致心血管疾病死亡的重要原因之一。目前对于HFpEF-AF的发病机制及治疗没有统一的金标准,对其诊疗仍然基于病人的表现和临床工作者的经验。本文就HFpEF-AF的流行病学、发病机制和治疗选择的相关知识做一系统综述。The increased incidence of ejection fraction preserved heart failure (HFpEF) combined with atrial fibrillation (AF) is increasing, which is one of the important causes of cardiovascular disease mortal-ity. At present, there is no recognized standard for the HFPEF-AF, and the diagnosis and treatment are still based on the manifestations of patients and the clinical experience of worker. This article summarized the epidemiological, pathophysiology, treatment options and prognosis of HFPEF-AF.

关 键 词：射血分数保留的心力衰竭合并房颤 流行病学 发病机制 治疗 

分 类 号：R541.6[医药卫生—心血管疾病]